What caused the recent jump in THCT stock?

The jump to $0.019 reflects a low-float, low-liquidity surge with volume above average. There was no major public earnings release; microcap trading, retail interest, or a short squeeze are likely drivers.

Is THCT stock a buy after the 4,650% move?

Given negative earnings, limited revenue per share, and small market cap, Meyka AI classifies THCT as high risk. The firm grade is B (HOLD); investors should wait for clear operational progress before buying.

What is Meyka AI's forecast for THCT stock?

Meyka AI's forecast model projects a 12-month price of $0.00047 versus current $0.019, implying an expected downside of about 97.51%. Forecasts are model-based projections and not guarantees.

Where can I find official THCT disclosures?

Use the company's website at https://thct.io for press releases and filings, and check exchange listings on PNK for trade details and timestamped volume.

US Stocks

THCT stock rises 4,650% to $0.019 on PNK: short-term volume spike flags high volatility

ByDanny Kontos February 5, 2026February 5, 2026

THCT stock jumped 4,650.00% to $0.019 in market hours on 05 Feb 2026 on the PNK exchange in the United States, driven by a swing from a prior close near $0.000. This move came with modest volume of 9,533.00 shares versus a 50-day average of 2,190.00, highlighting a low-float surge. We analyze the price action, financial profile, trading signals, and Meyka AI forecasting to outline risk and opportunity for investors in THC Therapeutics, Inc. (THCT) trading in USD on PNK